Product name | Empagliflozin |
CAS No. | 864070-44-0 |
Molecular Formula | C23H27ClO7 |
Molecular Weight | 450.91 |
Quality Standard | 99.5% up by HPLC, Medical Grade |
Appearance | White powder |
Item | Specification | Test Result |
Characteristics | White or almost white powder | White powder |
Solubility | Practically insoluble in water: freely soluble in methylene chloride; Sparingly soluble in acetone(96%); slightly soluble in alcohol (96%) | Conforms |
M.P | 162-166°C | 164.0-164.5° C |
Identification | Conform to the spectrum of the CRS Gliclazide | Conforms |
Heavy metals | ≤10ppm | <10ppm |
Impurity B | ≤2ppm | 0.3ppm |
Related substances | Impurity F ≤0.10% | <0.10% |
Other single impurity ≤0.10% | <0.10% |
Total of other impurities ≤0.2% | <0.13% |
Loss on drying | ≤0.25% | 0.10% |
Sulphated ash | ≤0.1% | 0.01% |
Residual solvents | Ethyl acetate ≤0.5% | Below LOQ |
Toluene ≤0.089% | Below LOQ |
Assay (on dried basis) | 99.0%-101.0% | 99.5% |
Conclusion | The Results Conforms With Enterprise Standards |
Function of Empagliflozin
Empagliflozin tablet is a new type of hypoglycemic drug, which can reduce the blood sugar level of patients and protect the liver and kidney function of patients. In addition, it also has a certain protective effect on the cardiovascular system of patients. When Empagliflozin tablets are used alone, patients often have lower blood sugar levels than before, and hypoglycemia rarely occurs. It is recommended that patients pay attention to monitoring the blood glucose level during the oral administration of Empagliflozin tablets. If Empagliflozin is used alone, the blood sugar level is not lowered well, it can also be combined with metformin or acarbose or other Hypoglycemic drugs.
